Literature DB >> 29134256

[Extragenital, disseminated infection with human papillomaviruses : Therapeutic response through vaccination with HPV].

L Wiskemann1, B Durani2, W Hartschuh2,3.   

Abstract

A 50-year-old man with widespread manifestation of warts and distinct pruritus for the last 5 years was diagnosed with a reactivated human papillomavirus (HPV) infection by three, genetically verified types (6, 16, 18), which are included in the vaccine Gardasil®. Conventional treatment was not successful, but a rapid and significant reduction of the skin manifestation was observed after vaccination with Gardasil®. To what extent therapy-resistant infections with HPV can be influenced through an active HPV vaccination should be investigated in future trials.

Entities:  

Keywords:  Gardasil® vaccination; Papillomatosis; Pruritus; Reactivation; Therapy resistance

Mesh：

Substances：

Year:  2018        PMID： 29134256     DOI： 10.1007/s00105-017-4077-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  10 in total

1.  Recalcitrant cutaneous warts treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man.

Authors:  Supriya S Venugopal; Dedee F Murrell
Journal:  Arch Dermatol       Date:  2010-05

2.  Regression of cutaneous warts in a patient with WILD syndrome following recombinant quadrivalent human papillomavirus vaccination.

Authors:  Alexander Kreuter; Tim Waterboer; Ulrike Wieland
Journal:  Arch Dermatol       Date:  2010-10

Review 3.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

4.  Atopic dermatitis associated with HPV 38 lower leg verrucosis.

Authors:  Elzbieta A Slodkowska; Joseph Schwartz; Peter L Rady; Stephen K Tyring; J Andrew Carlson
Journal:  Am J Dermatopathol       Date:  2010-08       Impact factor: 1.533

5.  Genital and extra-genital warts increase the risk of asymptomatic genital human papillomavirus infection in men.

Authors:  Brenda Y Hernandez; Yurii B Shvetsov; Marc T Goodman; Lynne R Wilkens; Pamela J Thompson; Xuemei Zhu; James Tom; Lily Ning
Journal:  Sex Transm Infect       Date:  2011-05-20       Impact factor: 3.519

6.  A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States.

Authors:  Patti E Gravitt; Anne F Rositch; Michelle I Silver; Morgan A Marks; Kathryn Chang; Anne E Burke; Raphael P Viscidi
Journal:  J Infect Dis       Date:  2012-12-12       Impact factor: 5.226

7.  [Recurrent respiratory papillomatosis: indication for HPV vaccination?].

Authors:  M Pawlita; L Gissmann
Journal:  Dtsch Med Wochenschr       Date:  2009-04-07       Impact factor: 0.628

8.  Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial.

Authors:  Allan Hildesheim; Rolando Herrero; Sholom Wacholder; Ana C Rodriguez; Diane Solomon; M Concepcion Bratti; John T Schiller; Paula Gonzalez; Gary Dubin; Carolina Porras; Silvia E Jimenez; Douglas R Lowy
Journal:  JAMA       Date:  2007-08-15       Impact factor: 56.272

9.  The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation.

Authors:  Joshua C Pritchett; Radu M Nanau; Manuela G Neuman
Journal:  Int J Hepatol       Date:  2012-05-16

Review 10.  Perspectives for therapeutic HPV vaccine development.

Authors:  Andrew Yang; Emily Farmer; T C Wu; Chien-Fu Hung
Journal:  J Biomed Sci       Date:  2016-11-04       Impact factor: 8.410
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.